Literature DB >> 24214884

Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.

Benjamin S Wessler1, David E Thaler, Robin Ruthazer, Christian Weimar, Marco R Di Tullio, Mitchell S V Elkind, Shunichi Homma, Jennifer S Lutz, Jean-Louis Mas, Heinrich P Mattle, Bernhard Meier, Krassen Nedeltchev, Federica Papetti, Emanuele Di Angelantonio, Mark Reisman, Joaquín Serena, David M Kent.   

Abstract

BACKGROUND: Patent foramen ovale (PFO) is associated with cryptogenic stroke (CS), although the pathogenicity of a discovered PFO in the setting of CS is typically unclear. Transesophageal echocardiography features such as PFO size, associated hypermobile septum, and presence of a right-to-left shunt at rest have all been proposed as markers of risk. The association of these transesophageal echocardiography features with other markers of pathogenicity has not been examined. METHODS AND
RESULTS: We used a recently derived score based on clinical and neuroimaging features to stratify patients with PFO and CS by the probability that their stroke is PFO-attributable. We examined whether high-risk transesophageal echocardiography features are seen more frequently in patients more likely to have had a PFO-attributable stroke (n=637) compared with those less likely to have a PFO-attributable stroke (n=657). Large physiologic shunt size was not more frequently seen among those with probable PFO-attributable strokes (odds ratio [OR], 0.92; P=0.53). The presence of neither a hypermobile septum nor a right-to-left shunt at rest was detected more often in those with a probable PFO-attributable stroke (OR, 0.80; P=0.45; OR, 1.15; P=0.11, respectively).
CONCLUSIONS: We found no evidence that the proposed transesophageal echocardiography risk markers of large PFO size, hypermobile septum, and presence of right-to-left shunt at rest are associated with clinical features suggesting that a CS is PFO-attributable. Additional tools to describe PFOs may be useful in helping to determine whether an observed PFO is incidental or pathogenically related to CS.

Entities:  

Keywords:  cardiovascular imaging; cerebrovascular disease/stroke; congenital heart disease; echocardiography; foramen ovale, patent; risk factor

Mesh:

Year:  2013        PMID: 24214884      PMCID: PMC3934652          DOI: 10.1161/CIRCIMAGING.113.000807

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  46 in total

Review 1.  Patent foramen ovale: current pathology, pathophysiology, and clinical status.

Authors:  Hidehiko Hara; Renu Virmani; Elena Ladich; Shannon Mackey-Bojack; Jack Titus; Mark Reisman; William Gray; Masato Nakamura; Michael Mooney; Anil Poulose; Robert S Schwartz
Journal:  J Am Coll Cardiol       Date:  2005-09-29       Impact factor: 24.094

2.  Patent foramen ovale and cryptogenic stroke in older patients.

Authors:  Michael Handke; Andreas Harloff; Manfred Olschewski; Andreas Hetzel; Annette Geibel
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

4.  Prevalence of patent foramen ovale in patients with stroke.

Authors:  P Lechat; J L Mas; G Lascault; P Loron; M Theard; M Klimczac; G Drobinski; D Thomas; Y Grosgogeat
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

5.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

Review 6.  Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence.

Authors:  Georgios D Kitsios; Issa J Dahabreh; Abd Moain Abu Dabrh; David E Thaler; David M Kent
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

Review 7.  Patent foramen ovale: the known and the to be known.

Authors:  Shelby Kutty; Partho P Sengupta; Bijoy K Khandheria
Journal:  J Am Coll Cardiol       Date:  2012-05-08       Impact factor: 24.094

8.  Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients.

Authors:  Sachin S Goel; E Murat Tuzcu; Mehdi H Shishehbor; Eduardo I de Oliveira; Przemyslaw P Borek; Richard A Krasuski; Leonardo L Rodriguez; Samir R Kapadia
Journal:  Am J Cardiol       Date:  2008-10-30       Impact factor: 2.778

9.  Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study.

Authors:  Marco R Di Tullio; Shunichi Homma; Zhezhen Jin; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2008-09-02       Impact factor: 24.094

10.  The risk of paradoxical embolism (RoPE) study: initial description of the completed database.

Authors:  David E Thaler; Emanuele Di Angelantonio; Marco R Di Tullio; Jennifer S Donovan; John Griffith; Shunichi Homma; Cheryl Jaigobin; Jean-Louis Mas; Heinrich P Mattle; Patrik Michel; Marie-Luise Mono; Krassen Nedeltchev; Federica Papetti; Robin Ruthazer; Joaquín Serena; Christian Weimar; Mitchell S V Elkind; David M Kent
Journal:  Int J Stroke       Date:  2012-08-09       Impact factor: 5.266

View more
  15 in total

1.  Controversies in cardioembolic stroke.

Authors:  Benjamin S Wessler; David M Kent
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

Review 2.  Prevention of recurrent stroke in patients with patent foramen ovale.

Authors:  Benjamin S Wessler; David M Kent
Journal:  Neurol Clin       Date:  2015-02-28       Impact factor: 3.806

3.  Reply.

Authors:  José María Trejo-Gabriel-Galán
Journal:  Neurologia       Date:  2021-04-09       Impact factor: 3.109

4.  The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study.

Authors:  Benjamin S Wessler; David M Kent; David E Thaler; Robin Ruthazer; Jennifer S Lutz; Joaquín Serena
Journal:  Cerebrovasc Dis       Date:  2015-07-11       Impact factor: 2.762

5.  Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database".

Authors:  Benjamin S Wessler; David E Thaler; Robin Ruthazer; Christian Weimar; Marco R Di Tullio; Mitchell S V Elkind; Shunichi Homma; Jennifer S Lutz; Jean-Louis Mas; Heinrich P Mattle; Bernhard Meier; Krassen Nedeltchev; Federica Papetti; Emanuele Di Angelantonio; Mark Reisman; Joaquín Serena; David M Kent
Journal:  Circ Cardiovasc Imaging       Date:  2014-05       Impact factor: 7.792

Review 6.  Patent foramen ovale and stroke.

Authors:  Bruno Miranda; Ana Catarina Fonseca; José M Ferro
Journal:  J Neurol       Date:  2018-04-21       Impact factor: 4.849

Review 7.  Role of Echocardiography in Assessment of Cardioembolic Sources: a Strong Diagnostic Resource in Patients with Ischemic Stroke.

Authors:  Luca Longobardo; Concetta Zito; Scipione Carerj; Giuseppe Caracciolo; Matt Umland; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

8.  Endocardial Device Leads in Patients with Patent Foramen Ovale: Echocardiographic Correlates of Stroke/TIA and Mortality.

Authors:  Shiva P Ponamgi; Vaibhav R Vaidya; Christopher V Desimone; Amit Noheria; David O Hodge; Joshua P Slusser; Naser M Ammash; Charles J Bruce; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  Pacing Clin Electrophysiol       Date:  2017-02-07       Impact factor: 1.976

9.  Ischemic stroke subtypes and migraine with visual aura in the ARIC study.

Authors:  X Michelle Androulakis; Nishanth Kodumuri; Lauren D Giamberardino; Wayne D Rosamond; Rebecca F Gottesman; Eunsil Yim; Souvik Sen
Journal:  Neurology       Date:  2016-11-09       Impact factor: 9.910

Review 10.  Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.

Authors:  Brunilda Alushi; Alexander Lauten; Salvatore Cassese; Roisin Colleran; Stefanie Schüpke; Himanshu Rai; Heribert Schunkert; Bernhard Meier; Ulf Landmesser; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2018-04-11       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.